AKR1D1 is down-regulated in patients with type 2 diabetes and we have recently shown asimilar decrease in expression with advancing severity of non-alcoholic fatty liver disease(NAFLD) (Valanejad et al. 2018,Nikolaou et al. 2019b). This evidence concerns the gene AKR1D1 and type 2 diabetes mellitus.